259 related articles for article (PubMed ID: 22353833)
41. Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?
Passaperuma K; Warner E; Hill KA; Gunasekara A; Yaffe MJ
J Clin Oncol; 2010 Aug; 28(23):3779-83. PubMed ID: 20625126
[TBL] [Abstract][Full Text] [Related]
42. Retrospective quantification of background incidence and stage distribution of breast cancer for the mammography screening pilot project in Wiesbaden, Germany.
Schott G; Reichel M; Junkermann H; Becker N
J Cancer Res Clin Oncol; 2008 Jan; 134(1):29-35. PubMed ID: 17602243
[TBL] [Abstract][Full Text] [Related]
43. Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year.
Jacklyn G; Morrell S; McGeechan K; Houssami N; Irwig L; Pathmanathan N; Barratt A
Breast; 2018 Feb; 37():170-178. PubMed ID: 28882419
[TBL] [Abstract][Full Text] [Related]
44. Increasing trends in in situ breast cancer incidence in a region with no population-based mammographic screening program: results from Zurich, Switzerland 2003-2014.
Karavasiloglou N; Matthes KL; Berlin C; Limam M; Wanner M; Korol D; Rohrmann S
J Cancer Res Clin Oncol; 2019 Mar; 145(3):653-660. PubMed ID: 30547321
[TBL] [Abstract][Full Text] [Related]
45. [Breast ductal carcinoma in situ. The clinical image in the mammogram].
Mallek R; Mostbeck GH; Czerwenka K; Fitzal P; Wolf G
Rofo; 1994 Jan; 160(1):30-4. PubMed ID: 8305689
[TBL] [Abstract][Full Text] [Related]
46. [Metachronous tumors of the breast. Mammographic findings].
Tella S; Occhiato R; Speziale AM; Poggi R; Grasso F; Frasca F; Passariello R
Radiol Med; 1994 Mar; 87(3):245-9. PubMed ID: 8146360
[TBL] [Abstract][Full Text] [Related]
47. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
48. Overdiagnosis in organised mammography screening in Denmark. A comparative study.
Jørgensen KJ; Zahl PH; Gøtzsche PC
BMC Womens Health; 2009 Dec; 9():36. PubMed ID: 20028513
[TBL] [Abstract][Full Text] [Related]
49. Spectrum of mammographically detected breast cancers.
Sener SF; Winchester DJ; Winchester DP; Kurek R; Motykie G; Martz CH; Rabbitt S
Am Surg; 1999 Aug; 65(8):731-5; discussion 735-6. PubMed ID: 10432082
[TBL] [Abstract][Full Text] [Related]
50. [Incidence of breast cancer before and after implementation of mammography screening].
Hofvind S; Sørum R; Haldorsen T; Langmark F
Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2935-8. PubMed ID: 17117191
[TBL] [Abstract][Full Text] [Related]
51. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
[TBL] [Abstract][Full Text] [Related]
52. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
[TBL] [Abstract][Full Text] [Related]
53. Mammogram screening of Chinese women in Kwong Wah Hospital, Hong Kong.
Chan LK; Lam HS; Chan ES; Lau Y; Chan M; Gwi E; Leung TY
Australas Radiol; 1998 Feb; 42(1):6-9. PubMed ID: 9509595
[TBL] [Abstract][Full Text] [Related]
54. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?
Paci E; Warwick J; Falini P; Duffy SW
J Med Screen; 2004; 11(1):23-7. PubMed ID: 15006110
[TBL] [Abstract][Full Text] [Related]
55. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
Swedish Organised Service Screening Evaluation Group
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
[TBL] [Abstract][Full Text] [Related]
56. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Ponti A; Rosso S; Zanetti R; Ricceri F; Tomatis M; Segnan N
J Natl Cancer Inst; 2007 Dec; 99(23):1817-8; author reply 1819. PubMed ID: 18042935
[No Abstract] [Full Text] [Related]
57. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Kerlikowske K; Miglioretti DL; Buist DS; Walker R; Carney PA;
J Natl Cancer Inst; 2007 Sep; 99(17):1335-9. PubMed ID: 17698950
[TBL] [Abstract][Full Text] [Related]
58. Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age.
Evans WP; Starr AL; Bennos ES
Radiology; 1997 Aug; 204(2):489-91. PubMed ID: 9240541
[TBL] [Abstract][Full Text] [Related]
59. Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence.
Buist DS; Walker R; Bowles EJ; Carney PA; Taplin SH; Onega T; Kerlikowske K; Clinton W; Miglioretti DL
Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):720-7. PubMed ID: 22301831
[TBL] [Abstract][Full Text] [Related]
60. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Robbins AS; Clarke CA
J Natl Cancer Inst; 2007 Dec; 99(23):1815; author reply 1816-7. PubMed ID: 18042938
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
